Novel Mode of Action of Angiotensin I Converting Enzyme Inhibitors
Open Access
- 1 May 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (19), 16847-16852
- https://doi.org/10.1074/jbc.m200355200
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Induction of Functional Bradykinin B 1 -Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor TreatmentCirculation, 2002
- Synergistic Antihypertensive Effects of Nifedipine on EndotheliumHypertension, 2001
- Replacement of the Transmembrane Anchor in Angiotensin I-converting Enzyme (ACE) with a Glycosylphosphatidylinositol Tail Affects Activation of the B2 Bradykinin Receptor by ACE InhibitorsJournal of Biological Chemistry, 2000
- Upregulation of bradykinin B1-receptor expression after myocardial infarctionBritish Journal of Pharmacology, 2000
- Role of kinins in the endothelial protective effect of ischaemic preconditioningBritish Journal of Pharmacology, 1998
- Families of zinc metalloproteasesFEBS Letters, 1994
- Angiotensin-converting enzyme inhibition in congestive heart failure: Benefit and perspectiveAmerican Heart Journal, 1993
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971